BridgeMD
Tests treatment safety and results for Pyramidal Tract-related Spasticity
Official title The Effectiveness of Different Pulse Duration of NMES in Patients With Pyramidal Tract-related Spasticity Measured by Neurophysiological Tools
ClinicalTrials.gov ID: NCT07321158
What this study is testing
- What it's testing
- Spasticity is a common symptom that affects more than 50% of patients with upper motor neuron lesions due to damage on pyramidal tract. Despite the current pharmacological and physical therapy rehabilitation methods, previous studies have highlighted the beneficial role of Neuromuscular Electrical Stimulation (NMES) on managing upper limb spasticity.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- diagnosis by neurologist with first damage of pyramidal tract with upper limb spasticity
- absence of cognitive dysfunction
- normal vital signs
- absence of pharmacological treatment of spasticity (per os pharmacological treatment does not affect spasticity results and was not an
You likely can't join if
- on patients' recruitment). Exclusion Criteria:
- prior neurological damage to pyramidal tract
- cognitive decline
- dermatological damages
- prior musculoskeletal dysfunction on the upper limb with spasticity
- presence of metallic residues on the spastic upper limb
See the full eligibility criteria
- diagnosis by neurologist with first damage of pyramidal tract with upper limb spasticity
- absence of cognitive dysfunction
- normal vital signs
- absence of pharmacological treatment of spasticity (per os pharmacological treatment does not affect spasticity results and was not an
- on patients' recruitment). Exclusion Criteria:
- prior neurological damage to pyramidal tract
- cognitive decline
- dermatological damages
- prior musculoskeletal dysfunction on the upper limb with spasticity
- presence of metallic residues on the spastic upper limb
- presence of seizures or psychiatric disorders
- severe malformation or obesity (BMI \>30kg/m2)
- history of coronary or other cardiovascular diseases (deep vein thrombosis, pulmonary embolism)
- presence of systematic inflammatory disease
- cancer on terminal stages
- pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Athens, Attica, Greece
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Athens, Attica, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.